https://iris.unicampania.it/handle/11591/189324
Reliable resequencing of the human dystrophin locus by universal long polymerase chain reaction and...
polymerase chain reactionof thereliableresequencinghuman
https://refex.dbcls.jp/gene_info.php?lang=ja&db=human&geneID=1756&refseq=NM_004009&unigene=Hs.495912&probe=203881_s_at
RefEx - dystrophin
dystrophin
https://www.omia.org/gene398298954/
Gene DMD : dystrophin in Macaca mulatta OMIA - Online Mendelian Inheritance in Animals
macaca mulattamendelian inheritancegenedmddystrophin
https://dmdwarrior.com/de/tag/micro-dystrophin/
Neuigkeiten, Forschungsergebnisse, klinische Studien und Artikel zu Mikro-Dystrophin – DMD Warrior
Neuigkeiten, die Sie interessieren, über Micro-Dystrophin: Aktuelle Artikel, klinische Studien, Forschungsergebnisse, Pressemitteilungen und alle bisherigen...
neuigkeitenklinischestudienundartikel
https://jci.org/articles/view/7866/pdf
JCI - Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice
aminoglycoside antibioticsskeletal musclesjcirestoredystrophin
https://insight.jci.org/articles/view/95918/figure/1
JCI Insight - Functional correction of dystrophin actin binding domain mutations by genome editing
jci insightbinding domaingenome editingfunctionalcorrection
https://tevard.com/tevard-to-present-data-demonstrating-trna-based-therapy-rescued-full-length-dystrophin-and-motor-function-in-duchenne-muscular-dystrophy-model/
Tevard to Present Data Demonstrating tRNA-based Therapy Rescued Full-Length Dystrophin and Motor...
Tevard to Present Data Demonstrating tRNA-based Therapy Rescued Full-Length Dystrophin and Motor Function in Duchenne Muscular Dystrophy Model
full lengthpresentdatademonstratingtrna
https://www.fda.gov/drugs/news-events-human-drugs/measuring-dystrophin-dystrophinopathy-patients-and-interpreting-data
Measuring Dystrophin in Dystrophinopathy Patients and Interpreting the Data | FDA
Measuring Dystrophin in Dystrophinopathy Patients and Interpreting the Data
the datameasuringdystrophinpatientsinterpreting
https://www.viltepso.com/efficacy-safety
Dystrophin Data & 4-Year Safety Results | VILTEPSO
Sep 30, 2026 - In a small clinical study (N=8), 100% of patients on VILTEPSO showed an increase in dystrophin, from 0.6% to 5.9% of normal at Week 25. See Important Safety...
dystrophindatayearsafetyresults